The trajectory of companies tied to Sildenafil's past presents a complex investment picture . While the initial surge generated substantial gains, generic copies have significantly diminished revenue. https://bookmark-media.com/story21752821/copyright-s-flagship-product-and-big-pharma-a-risky-opportunity